In this article, we take a look at 10 Best Medical Care Facilities Stocks to Buy According to Analysts.
Medical care facilities remain at the center of U.S. healthcare spending, but the picture is more complex than a simple volume story. CMS reported that national health expenditures rose 7.2% to $5.3 trillion in 2024, equal to 18.0% of GDP. Hospital care alone reached $1.63 trillion after growing 8.9%, while physician and clinical services reached $1.11 trillion after growing 8.1%. The American Hospital Association’s 2026 Fast Facts, based on its 2024 annual survey, counted 6,100 U.S. hospitals, 907,216 staffed beds, and roughly 35.7 million admissions. That is a large operating base, but it is also a demanding one, shaped by labor costs, payer mix, technology investment, site-of-care shifts, and regulatory pressure.
Within that backdrop, public medical care facility operators are being judged less on broad healthcare demand alone and more on whether their assets can support profitable access, higher-acuity services, outpatient expansion, rehabilitation, diagnostics, or home-based alternatives. Analysts remain selective. The stocks that screen well tend to combine direct exposure to care delivery with visible operating levers, whether through facility expansion, specialty networks, acquisitions, care coordination, or scale in targeted service lines.
Against this backdrop, lets look at some medical care facilities stocks to buy according to analysts.
Igor Kardasov/Shutterstock.com
Methodology
To identify the best medical care facilities stocks to buy according to analysts, the screen focused on U.S.-traded companies involved in healthcare facility operations and direct care delivery. Greater weight was given to companies with purer exposure to hospitals, clinics, rehabilitation centers, diagnostic facilities, skilled nursing, and other care delivery settings. The stocks were then ranked by average analyst-consensus upside, using price-target data compiled by StockAnalysis from S&P Global, with a minimum upside threshold of 20%.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
10. HCA Healthcare, Inc. (NYSE:HCA)
HCA Healthcare, Inc. (NYSE:HCA) is one of the best medical care facilities stocks to buy according to analysts. The company ranks tenth on the list, with analysts seeing roughly 21.9% upside on average. The latest relevant development was clinical rather than purely financial: on June 29, HCA Healthcare announced new research published in The New England Journal of Medicine involving gene-editing therapy being studied in children ages 5 to 11 with severe sickle cell disease and transfusion-dependent beta thalassemia.
The story matters because it highlights the specialized capability embedded inside large hospital systems. HCA said the work builds on programs tied to TriStar Centennial Medical Center and the Sarah Cannon Transplant and Cellular Therapy Network, which performs more than 1,600 blood and marrow transplants and cellular therapies annually. This does not make HCA a biotech stock, and it should not be treated that way. Rather, it points to the role high-acuity facilities can play in advanced care as hospitals compete on service depth, scale, and clinical infrastructure.
HCA Healthcare, Inc. (NYSE:HCA) operates acute care hospitals, surgery centers, freestanding emergency rooms, urgent care centers, and physician clinics across the United States and the United Kingdom.
9. Nutex Health Inc. (NASDAQ:NUTX)
Nutex Health Inc. (NASDAQ:NUTX) is one of the best medical care facilities stocks to buy according to analysts. Analysts’ average target implies about 25.4% upside, although the stock carries wider target dispersion than larger facility operators, making the risk-reward profile less straightforward. The freshest investor-relevant development came on June 29, when STAT reported on Nutex’s microhospital model and its use of No Surprises Act arbitration. STAT reported that, after Nutex began filing arbitration disputes, revenue tripled and profit grew nearly twelvefold.
That is directly relevant to the investment debate because it touches reimbursement, cash generation, and the economics of small-format emergency and hospital-based care. The model gives Nutex exposure to a focused care setting, but it also ties performance closely to payer disputes and collections. The upside case is therefore not just about facility growth or patient volume. It depends on whether Nutex can sustain profitability while navigating scrutiny around out-of-network billing and reimbursement rules.
Nutex Health Inc. (NASDAQ:NUTX) is a healthcare management and operations company whose Hospital Division owns, develops, and operates micro-hospitals, specialty hospitals, and hospital outpatient departments.
Hedge Fund Resource Center